1. Home
  2. LSE vs GALT Comparison

LSE vs GALT Comparison

Compare LSE & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSE
  • GALT
  • Stock Information
  • Founded
  • LSE 2007
  • GALT 2000
  • Country
  • LSE China
  • GALT United States
  • Employees
  • LSE N/A
  • GALT N/A
  • Industry
  • LSE Metal Fabrications
  • GALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSE Industrials
  • GALT Health Care
  • Exchange
  • LSE Nasdaq
  • GALT Nasdaq
  • Market Cap
  • LSE 85.6M
  • GALT 83.5M
  • IPO Year
  • LSE 2024
  • GALT N/A
  • Fundamental
  • Price
  • LSE $5.76
  • GALT $2.52
  • Analyst Decision
  • LSE
  • GALT Buy
  • Analyst Count
  • LSE 0
  • GALT 2
  • Target Price
  • LSE N/A
  • GALT $6.00
  • AVG Volume (30 Days)
  • LSE 1.4M
  • GALT 1.5M
  • Earning Date
  • LSE 05-08-2013
  • GALT 08-12-2025
  • Dividend Yield
  • LSE N/A
  • GALT N/A
  • EPS Growth
  • LSE N/A
  • GALT N/A
  • EPS
  • LSE 0.52
  • GALT N/A
  • Revenue
  • LSE $69,073,374.00
  • GALT N/A
  • Revenue This Year
  • LSE N/A
  • GALT N/A
  • Revenue Next Year
  • LSE N/A
  • GALT N/A
  • P/E Ratio
  • LSE $11.01
  • GALT N/A
  • Revenue Growth
  • LSE N/A
  • GALT N/A
  • 52 Week Low
  • LSE $3.76
  • GALT $0.73
  • 52 Week High
  • LSE $14.99
  • GALT $3.90
  • Technical
  • Relative Strength Index (RSI)
  • LSE N/A
  • GALT 63.30
  • Support Level
  • LSE N/A
  • GALT $2.07
  • Resistance Level
  • LSE N/A
  • GALT $2.36
  • Average True Range (ATR)
  • LSE 0.00
  • GALT 0.27
  • MACD
  • LSE 0.00
  • GALT -0.01
  • Stochastic Oscillator
  • LSE 0.00
  • GALT 61.64

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: